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ABSTRACT
Measurements of oxidative metabolic
capacity following the ablation of rat sensori-
motor cortex and the administration of am-
phetamine were examined to determine their
effects on the metabolic dysfunction that
follows brain injury. Twenty-four hours after
surgery, rats sustaining either sham operations
or unilateral cortical ablation were administered
a single injection of D-amphetamine (2 mg/kg;
i.p.) or saline and then sacrificed 24 h later.
Brain tissue was processed for cytochrome
oxidase histochemistry, and 12 bilateral cerebral
areas were measured, using optical density as
an index of the relative amounts of the
enzyme. Compared with that of the control
groups, cytochrome oxidase in the injured
animals was significantly reduced throughout
the cerebral cortex and in 5 of 11 subcortical
structures. This injury-induced depression of
oxidative capacity was most pronounced in
regions of the hemisphere ipsilateral to the
ablation. Animals given D-amphetamine had
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less depression of oxidative capacity, which
was most pronounced bilaterally in the cerebral
cortex, red nucleus, and superior colliculus;
and in the nucleus accumbens, caudate-
putamen, and globus pallidus ipsilaterai to the
ablation. The ability of D-amphetamine to
alleviate depressed cerebral oxidative metabolism
following cortical injury may be one mechanism
by which drugs increasing noradrenaline
release accelerate functional recovery in both
animals and humans.
KEYWORDS
cerebral oxidative metabolism, diaschisis, stroke,
remote functional depression; cytochrome oxidase
INTRODUCTION
Short term treatment(s) with D-amphetamine
(AMPH), when administered late after a unilateral
sensorimotor cortex ablation, embolic stroke, or
traumatic brain injury (TBI) and combined with
physical therapy (PT), results in an enduring
acceleration of recovery from hemiplegia in rats
and cats (Feeney et al., 1982; Hovda & Feeney,
1984; Sutton et al., 1987; Feeney & Westerberg,
1990; Sutton & Feeney, 1992; Feeney 1998a).
(C)Freund & Pettrnan, U.K., 2000 109
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The efficacy of this experimental treatment
protocol may require adjustment of the (a) drug
dosage, (b) number of treatments, or (c) delay
between injury and initiation of therapy,
depending on species, injury severity, and type of
injury. Significantly, AMPH treatment may be
contraindicated after damage to some brain
regions producing motor symptoms, such as
cerebellar deep nuclei (Boyeson & Feeney, 1991)
or the substantia nigra (Mintz & Toner, 1989). In
rats with unilateral sensorimotor cortex ablation,
a single low dose of AMPH combined with PT,
given one day after surgery, significantly enhances
ftmctional recovery (Feeney et al., 1982; Goldstein,
1988; Sutton & Feeney, 1992). Rats with embolic
or photothrombotic stroke require multiple and/
or higher doses of AMPH, beginning 1 day after
infarct, to promote functional recovery from
hemiplegia (Salo & Feeney, 1987; Hurwitz et al.,
1991). Cats with unilateral or bilateral frontal
lobe ablation require three high doses of AMPH,
beginning 10 days after injury, for drug-induced
acceleration of beam-walking recovery to occur
(Hovda & Feeney, 1984; Sutton et al., 1989b). In a
few clinical trials, this beneficial effect of
treatment with AMPH + PT was extended to
hemiplegic stroke patients, with preliminary
work on aphasic stroke patients (Walker-Batson et
al., 1992; 1995; for review, see Goldstein, 1993;
Feeney, 1997; 1998a; 1998b). The recovery from
hemiplegia of patients receiving short-term
treatment with AMPH + PT, begun as long as 1
month after stroke, was significantly enhanced
when compared with that of patients given
placebo + PT. Significantly, this benficial effect
of a 10-week treatment was enduring because it
remained significant for months after
discontinuing treatment for the 1-year period of
study (Walker-Batson et al., 1995). This
opportunity to delay treatment for stroke or TBI
is very important because it allows the physician
time to make a full evaluation and to stabilize the
patients before initiating therapy. Significantly,
the vast majority of stroke patients do not seek
medical attention within the first 3 to 6 hours
after an infarct, when alternative treatments for
stroke are most effective (Ginsberg & Pulsinelli,
1994), and thus can suffer significant side effects
(Bath, 1995). Clearly, further development and
evaluation of potential therapies that can be
initiated late after brain injury to promote
recovery are needed.
The mechanism(s) by which AMPH promotes
functional recovery after cortical injury are not
well understood. It has been established that
essential components of AMPH therapy include
the release of cerebral noradrenaline (NA) and
the provision of PT during the period of drug
action. Using the rat model of unilateral sensori-
motor cortex ablation, several studies have shown
that any of the family of drugs increasing the
release of central NA can promote functional
recovery when combined with PT (Feeney &
Westerberg, 1990; Goldstein & Davis, 1990; Feeney,
1991; 1998a; Sutton & Feeney, 1992; Boyeson &
Harmon, 1993; Goldstein, 1993; Boyeson et al.,
1994; Feeney et al., 1994). In addition, intraven-
tricular infusion of NA, but neither dopamine
(Boyeson & Feeney, 1990) nor serotonin (Boyeson
et al., 1994; Feeney, personal observations), promotes
recovery from hemiplegia after cortical injury.
The requirement for PT during the period of drug
action to optimize functional recovery after
AMPH treatment suggests an interaction between
two processes during this experimental treatment.
As originally proposed (Feeney et al.; 1985;
Feeney & Sutton, 1987) and subsequently
expanded (Feeney, 1998a; 1998b), the two processes
involve drug release of the neuromodulator NA
which, by alleviating hypometabolic regions,
"enables" PT to act upon intact but nonfunctional
"performance" circuits that are normally involved
in the behaviors that are lost after injury. These
afferent inputs are thought to be both
proprioceptive feedback and corollary discharges
from the attempted movement. The mechanisms
resulting from these processes are unknown, but
several have been hypothesized, including
(a) NA-induced unmasking or permitting the use
of alternative pathways (Dietrich et al., 1990),
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(b) enhancing attention by increasing the signal-
to-noise ratio of unit activity evoked during PT
(Segal & Bloom, 1976a, 1976b; Woodard et al.,
1979; Robbins et al., 1985), or (c) enhancing long-
term potentiation as a model of plasticity (Gold
et al., 1984).
Our own research on the mechanisms of
AMPH-induced functional recovery has focused
on the ability of this treatment to alleviate an
injury-induced metabolic depression in morpho-
logically intact brain tissue, remote from the
primary injury. The concept of remote functional
depression, or diaschisis, following brain injury
has a long history, but only recently have techniques
been developed for measuring neuronal function.
This evolving concept has been reviewed
elsewhere (Feeney & Baron, 1986; Feeney, 1991).
Studies reporting that injury to the cerebral
cortex produces widespread alterations in both
glycolytic (Pappius, 1981; Feeney et al., 1985;
Hosokawa et al., 1985; Gilman et al., 1987; Sutton et
al., 1989a; Yoshino et al., 1991; Hovda et al., 1996;
Queen et al., 1997) and oxidative (Feeney et al., 1985;
Hovda et al., 1991; Hovda & Villablanca, 1998)
metabolism substantially support the concept of
an injury-induced remote functional depression.
In a number of studies, functional recovery from
injury-induced neurobehavioral deficits has been
correlated with an alleviation of depressed
cerebral metabolism (Colleet al., 1986; Gilman et
al., 1987; Hovda et al., 1987; Hovda & Villablanca,
1990; Hovda, 1996).
The concept that producing a functional
depression and reduction of neuronal excitability
contributes to the symptoms of brain injury is
supported by the work of Brailowsky et al.
(1986). In his work, Dr. Brailowsky reported that
the short-lasting hemiplegia induced by the
insertion of saline-filled osmotic minipumps into
the sensorimotor cortex of rats was potentiated
when the minipumps were filled with GABA. In
essence, this worsening of hemiplegia by GABA
can be viewed as a drug-induced diaschisis or
remote functional depression. Others have reported
drug-induced remote functional depression (Khan
et al., 1997). During a selective anterior temporal
lobe (TL)amobarbital test, aimed at inactivation
of the mesiobasal TL structures, the authors
measured cerebral glucose utilization using 18F-
fluoro-deoxyglucos positron emission tomography
(18F-FDG PET) in temporal lobe epilepsy
patients. A decreased glucose uptake resulting
from amobarbital application was observed, in
addition to the intended ipsilateral anterior TL
area. All patients showed decreased glucose
uptake in contralateral temporolateral regions,
and one-half showed "cerebellar diaschisis". This
observation indicates that the simple drug
inactivation of local regions produces local and
remote metabolic deafferentation. Removal of
afferent input is sufficient to produce a diaschisis
or hypometabolic response. This simple
deafferentation must be included with other post-
injury events that are hypothesized to produce
remote functional depression, such as sublethal
exeitotoxieity and sensorimotor imbalance,
producing a remote functional depression by
altering calcium ion homeostasis (Feeney, 1998a).
Whereas all these post-injury events may
produce diaschisis, none is essential.
Alleviation of remote metabolic depression
after brain injury by drugs increasing cerebral
NA has been reported in both the rat (Feeney et
al., 1985; Feeney & Sutton, 1987; 1988; Feeney,
1991; 1998b; Hovda, 1996) and the cat (Hovda et al.,
1987). In rat studies addressing the metabolic
depression that is associated with fluid percussion
TBI, Hovda (1996) reported that the degree and
extent of injury-induced depression of cerebral
glucose metabolism is a predictor of functional
performance on both sensorimotor and cognitive
tasks. More important, a single administration of
AMPH (3 hours after the injury) alleviates this
trauma-induceA metabolic depression, complimented
by an enhancement in the rate of functional
recovery. In addition, widespread depression of
local cerebral glucose utilization (ICMRgle) in
cortical regions following a cortical freezing
lesion is prevented by pre-treatment with drugs
that either inhibit serotonin synthesis or block
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alpha-NA receptors (Pappius et al., 1988;
Pappius, 1991). The widespread depression of
1CMRglc after cortical infarct or TBI is reversed
or attenuated by post-injury administration of
AMPH, and this metabolic depression continues
to be alleviated long after the drug is metabolized
(Dietrich et al., 1990; Queen et al., 1997).
The ability of drug-induced NA release to
alleviate hypometabolism after brain injury may
be one underlying mechanism for the hypothesized
permissive action of NA. What mechanisms are
involved when PT is provided during NA increase
to produce the enduring enhancement of recovery
are not understood. Eliminating PT during the
period of AMPH action blocks any beneficial
effect of the drug on recovery, as has been
reported in hemiplegic rats and cats (Feeney et al.,
1982; Hovda & Feeney, 1984; Goldstein & Davis,
1990) and for alleviating some visual deficits in
cats following bilateral visual cortex ablation
(Feeney & Hovda, 1985). A possibly related drug/
experience interaction has been described in a
PET study of rCBF in normal human beings who
were given a low dose ofAMPH before performing
different tasks (Mattay et al., 1996). The data
from their study indicate that AMPH, rather than
having a fixed, global effect on rCBF, induces
task-specific activation in selective cortical regions
that are involved in the performance of behavioral
tasks. This AMPH/experience interaction suggests
that the brain area activated by NA depends upon
what task the animal or patient is doing during
the period of drug action.
Previously, we documented that AMPH can
induce an alleviation of a remote functional
depression of ICMRglc, measured 48 hours after
either unilateral sensorimotor cortex ablation or
TBI in the rat (Feeney et al., 1985; Queen et al.,
1997). Other authors have reported that short-
term treatment with AMPH produces an enduring
recovery of responsiveness to vibrissae stimula-
tion in a rat model of focal infarct to the cortical
vibrissae barrel fields (Dietrich et al., 1990).
During the period of AMPH action, alternative
neuronal circuits show activation during
vibrissae stimulation that is absent during
stimulation in normal rats or in injured rats given
saline. Given that glycolysis acts independently
from oxidative metabolism, a more complete
understanding of the effect of AMPH on cerebral
metabolic processes following brain injury
requires that both metabolic pathways be studied.
Little is known, however, regarding the effects of
brain injury and AMPH treatment on oxidative
metabolism. Therefore, the current study expands
our investigations of brain injury and AMPH
treatment to oxidative metabolism, examined
using cytochrome oxidase (C.O.) histochemistry
(Wong-Riley, 1979) to assess the effect of
AMPH on cerebral oxidative capacity atter brain
injury. In the C.O. histochemistry technique,
increases in staining intensity reflect increased
activity in the mitochondrial cytochrome chain,
which relates to energy production in the cell
(Wong-Riley, 1989). Previously, we used this
method to show that the accelerated recovery of
tactile placing, produced by AMPH treatment in
cats with bilateral visual cortex ablation, was
associated with an enduring increase in C.O.
activity in the superior colliculus weeks after the
injury (Hovda et al., 1987). The effect of AMPH
on oxidative capacity after sensorimotor cortex
ablation has not yet been studied, however.
Alteration of oxidative capacity after cortical
trauma was studied using C.O. histochemistry
(Weisend et al., 1990; Hovda et al., 1991).
Cortical contusion injury results in oxidative
hypometabolism near the injured cortex, as well
as in hypermetabolism in the entorhinal cortex
and the adjacent temporal lobe (Weisend et al.,
1990). It is not clear whether these mixed
metabolic effects are related to the numerous
pathological events after cortical contusion, but
not after ablation, including (a) selective neuronal
death of CA3 hippocampal pyramidal and hilar
neurons (Feeney et al., 1989), (b) multiple recurring
seizures within 3 hours after trauma (Krobert et al.,
1992; Nilsson et al., 1994), and (c) slow development
of a panecrosis after trauma. The current study
was conducted (a) to determine the effects of a
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unilateral sensorimotor cortex ablation on C.O.
activity 2 days after injury and (b) to determine
the effects of a single AMPH treatment, given
one day after cortical injury, on this measure of
oxidative capacity.
MATERIALS AND METHODS
Subjects
Sixteen male albino rats (Harlan, Sprague-
Dawley, 255 to 290 g), maintained in standard
wire cages on a 12:12 light:dark cycle and with
ad libitum access to food and water, were used in
the experiments. All procedures were approved
by the University of New Mexico Institutional
Review Board.
Surgery and group assignments
Animals were randomly assigned to sham
injury (N=8) or to ablation (N=8) groups before
surgery. After overnight fasting, the animals were
anesthetized with ketamine hydrochloride (60
mg/kg, i.m.) followed by sodium pentobarbital
(21 mg/kg, i.p.) and positioned in a stereotaxic
frame. Animals assigned to injury groups had the
right sensorimotor cortex ablated, as described
previously (Feeney et al., 1982; Sutton & Feeney,
1992). Twenty-four hours after surgery, one-half
of the animals in the sham (S) and injury (I)
groups were injected with either 0.9% saline
(SAL) or AMPH (2 mg/kg in saline, i.p.). The
groups were thus designated as S-SAL, S-AMPH,
I-SAL; and I-AMPH.
Cytochrome oxidase histochemistry
Twenty-four hours after SAL or AMPH
injection, the animals were overdosed with
sodium pentobarbital (100 mg/kg, i.p.) and perfused
transcardially with room-temperature 0.9% saline
(pH 7.4), followed by cold fixative solution
(2.5% paraformaldehyde, 1.5% glutaraldehyde,
4% sucrose in 0.1 M phosphate buffer [PB], pH
7.4, 4C). Brains were post-fixed for 1 h in cold
fixative and then cryoprotected by immersion in
succeeding concentrations (10%, 20%, 30%) of
sucrose/PB solution at 4C. Brains were frozen
(-22C) and then sectioned in the coronal plane
(40-um), and every fifth section throughout the
brain was mounted onto gelatin-coated slides.
After drying at room temperature, tissue sections
were processed for C.O. histochemistry, using
the procedure of Wong-Riley (1979). Briefly,
sections were reacted for 40 min (in the dark) in
an incubation medium (25C) consisting of 0.6%
diaminobenzadine (Sigma), 0.2% eytochrome C,
Type III (Sigma), and 4.5% sucrose in 0.1 M PB
(pH 7.4). The reaction was stopped using three
rinses in PB; the sections were air-dried and then
coverslipped using permount. Tissue sections
from all groups were simultaneously reacted in
each batch of incubation medium to reduce
between-group variability.
For quantifying C.O. activity, optical density
readings were taken bilaterally from the 12 gray
matter structures listed in Table 1, using a
manual densitometer (Sargent-Welch Densichron
Model PPD, with a 0.20 mm diameter aperture).
The regions chosen for study of C.O. activity
included the extrapyramidal structures previously
reported to show altered ICMRglc metabolism
after low-dose AMPH (Porrino et al., 1984) and/
or regions showing alterations in ICMRglc or
C.O. measures of metabolism after cortical injury
and AMPH treatment (Feeney et al. 1985; Hovda et
al., 1987; Queen et al., 1997). The readings were
taken by an investigator, blinded to the drug
treatment conditions of the animals, and were
corrected for background (namely, glass, permount,
and coverslip). For smaller structures (for example,
dorsal tegmental and subthalamic nuclei), a
minimum of two to five readings across two to
three different sections were taken. For larger
structures/regions (for example, cerebral cortex
[frontal, parietal, occipital], and the dorsal
caudate-putamen), as many as 30 to 38 separate
readings from 10 to 15 different sections were
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TABLE 1
Mean (+SD) optical density values (x 10) for cytochrome oxidase activity in brain structures ofthe left
(L) and right (R) hemisphere for rats with sham injury (S) or right sensorimotor cortex ablation (I)
Structure Experimental Group
S-SAL S-AMPH I-SAL I-AMPH
Cerebral L: 262.6 (17.7) 220.3 (5.8) 188.6 (14.3)** 226.6 (16.4)
Cortex R: 258.5 (19.4 237.0 (8.6) 181.4 (14.9)**, 221.9 (18.5)
Nucleus L: 246.3 (14.6) 241.0 (20.6) 196.4 (9.7) 239.7 (22.1)
Accumbens R: 248.5 (10.3) 242.0 (20.1 197.3 (9.0)* 241.4 (20.0)
Caudate L: 230.7 (15.8) 225.1 (14.1) 190.4 (9.4) 220.8 (15.0)
Putamen R: 230.3 (11.8) 228.7 (13.0) 192.9 (6.5)* 220.7 (14.9)
Globus L: 189.4 (15.0) 166.9 (21.2) 147.9 (19.9) 176.5 (3.3)
Pallidus R: 193.6 (14.2) 194.1 (11.4 152.9 (15.6)*, 183.5 (5.5)
Subthalamic L: 156.6 (14.8) 177.7 (11.0) 127.2 (11.6) 189.8 (29.9)
Nucleus R: 173.9 (23.7) 186.9 (10.5) 132.6 (12.0) 196.0 (31.2)
Substantia L: 227.9 (24.3) 222.2 (17.1) 189.2 (4.2) 193.8 (12.7)
Nigra R: 228.5 (24.1) 220.9 (20.1) 190.2 (5.8) 198.8 (16.2)
Lateral L: 263.5 (13.8) 234.3 (10.1) 225.0 (17.5) 231.4 (15.9)
Geniculate R: 260.3 (11.5) 234.3 (4.8) 224.1 (17.9) 232.6 (17.4)
Red L: 237.3 (19.5) 234.9 (18.3) 184.7 (4.1)*, 211.2 (10.5)
Nucleus R: 240.6 (19.1) 228.8 (13.7) 186.3 (5.7)*,$ 210.9 (12.7)
Superior L: 251.3 (16.8) 204.7 (15.0) 197.4 (18.3)* 213.7 (20.0)
Colliculus R: 252.6 (13.1) 207.2 (19.3) 198.7 (16.8)* 222.1 (13.2)
Locus L: 250.3 (27.3) 228.8 (16.0) 203.2 (23.6) 234.8 (25.9)
Coeruleus R: 242.9 (19.5) 223.5 (13.8) 202.9 (16.5) 238.1 (24.7)
Dorsal Tegmental L: 214.6 (25.5) 218.6 (14.5) 218.0 (20.5) 209.4 (11.6)
Nucleus R: 210.1 (27.6) 211.9 (12.5) 219.8 (23.8) 207.2 (14.9)
Cerebellar L: 257.1 (18.8) 243.2 (8.7) 224.3 (22.7) 255.9 (12.5)
Cortex R: 249.6 (17.3) 243.6 (10.1) 218.5 (24.5) 249.1 (11.2)
1Animals received either saline (SAL) or AMPH one day after surgery and were sacrificed 24 hours later.
* t2 <0.05 compared to S-SAL; ** 12 <0.01 compared to S-SAL; ;12 <0.05 compared to S-AMPH
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obtained. The mean optical density readings for
each structure was calculated for individual
animals and used to calculate the group means
for each structure (see Table 1). Thus, we
measured the relative (not absolute) values of
C.O., as we were interested in the relative
differences among the four treatment groups
rather than in the absolute amount of C.O. that
was present after injury or drug treatment.
Statistical analysis
For statistical analysis, separate repeated
measures analysis of variance were conducted
for right and left hemisphere structures, with the
individual structure serving as the repeated
variable. As side was not treated as a within-
subject factor, the degrees of freedom were
inflated. Given the a priori hypothesis of effects
being more prevalent in the hemisphere ipsilateral
to the lesion, however, we felt that these inde-
pendent comparisons were warranted. Following
the overall analysis incorporating a least-squares
approach, we then made comparisons to determine
the significance of the main effect (group), with
simple main effects comparisons being made
among groups using appropriate contrasts (Hays,
1973; Myers, 1979).
RESULTS
Extent of injury and stain quality
In both SAL- and AMPH-treated groups, the
cortical injuries were similar to those described
previously (Sutton & Feeney, 1992). In all animals,
cortical tissue, designated as the hindlimb and
forelimb sensorimotor areas (Hall & Lindholm,
1974), was removed unilaterally (right). Evaluation
of histological sections indicated that the lesions
extended to the depth of the white matter, from
0.8 to 4.0 mm lateral to midline, and from 3.5
mm anterior to 2.0 mm posterior to bregma in all
animals. The underlying hippocampus and caudate
were not surgically damaged, and no significant
differences were found among the groups with
respect to the rostral-caudal, medial-lateral, or
dorsal-ventral extent of cortical removal.
Perfusion fixation and the 40-minute reaction
in the incubation medium resulted in good
differential C.O. staining in various structures and
between white- and gray-matter regions. Whereas
robust differences in C.O. staining density can be
detected by densitometry (see Table 1), the effect
of ablation or drug on C.O. depression is difficult
to see photographically, so no such illustration is
included in this article.
Amphetamine effects in intact animals
The mean (+SD) optical density readings of
C.O. activity in the left and right cortex and
subcortical structures for the four groups are
shown in Table 1. Comparing values for the
S-SAL and S-AMPH groups shows that AMPH
treatment given to intact animals slightly reduced
C.O. activity in several regions, with the greatest
reductions occurring within the cerebral cortex,
the lateral geniculate, the superior colliculus, and
the locus coeruleus. When compared with S-SAL
animals, however, this AMPH effect was not
significant
Effect of injury on cytochrome oxidase
In several structures, unilateral cortical
ablation induced bilateral reductions in cerebral
oxidative metabolism 48 hours post injury.
Comparisons between S-SAL and I-SAL groups
revealed that right cortical injury resulted in
significant reductions in C.O. activity, which was
evident within the spared ipsilateral cortical tissue
(p<0.01), as well as in the right nucleus aeeumbens
(p<0.05), caudate-putamen (p<0.05), globus pallidus
(p<0.05), superior colliculus (p<0.05), and red
nucleus (p<0.05; see Table 1). Within the
contralateral hemisphere, C.O. activity was
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significantly decreased in the I-SAL group (vs.
S-SAL animals) in the cerebral cortex (p<0.01),
superior colliculus (p<0.05), and red nucleus
(p<0.03; Table 1). Comparisons were also made
between the S-AMPH and I-SAL groups.
Because of the slight reduction of oxidative
metabolism in the AMPH-treated intact animals,
only the left red nucleus and the right cerebral
cortex, globus pallidus, and red nucleus of I-SAL
rats showed significantly decreased C.O. activity
(p<0.05 for all) relative to measures in S-AMPH
animals (Table 1).
Amphetamine effects in injured animals
In animals with unilateral sensorimotor
cortex ablation, AMPH treatment eliminated the
ablation-induced loss of C.O. staining density,
restoring the C.O. stain intensity to near-normal
levels (see Table 1). This effect of AMPH was
bilateral and global, as the C.O. activity in both
the left and the right structures of I-AMPH rats
did not differ significantly from the metabolic
activity of corresponding structures of either
S-SAL or S-AMPH animals. Interestingly,
AMPH-induced attenuation of decreased C.O.
staining intensity occurred after cortical injury,
despite the trend of AMPH to decrease C.O.
activity in intact rats.
DISCUSSION
The results of the current study indicate that
restricted, unilateral ablation of the sensorimotor
cortex in rat is followed by a widespread
reduction in cerebral oxidative metabolism,
assessed using C.O. histoehemistry. The observed
reduction of this mitoehondrial enzyme in
morphologically intact regions, remote from the
site of injury, supports the concept of a remote
functional depression or a diasehisis. This
concept of distant effects of focal brain injury,
mediated by axonal connections to the damaged
area and resulting in a suppression of neuronal
activity that contributes to symptoms of brain
injury, has a long history (see Feeney, 1991 for
review). In addition, the current results indicate
that a single low dose ofAMPH can alleviate the
remote metabolic effects that occur following a
focal cortical injury.
Effect of brain injury on cerebral metabolism
Consistent with the results ofthe current study,
the results of numerous studies have
demonstrated hypometabolism in regions remote
from the primary injury (Ginsberg et al., 1977; Dail
et al., 1981; Nemoto et al., 1981; Pappius, 1982;
Pappius & Wolfe, 1983; Kushner et al., 1984; Dauth
et al., 1985; Colle et al., 1986; Hovda et al., 1987;
Kiyosawa et al., 1987; Lagreze et al., 1987; Beck et
al., 1990; Fiorelli et al., 1991; Yoshino et al., 1991;
Yoshino et a1.,1992; Bergsneider et al., 1997).
Widespread and remote metabolic depression
after brain injury has typically been studied using
2-deoxy-D-glucose (2-DG) autoradiography to
measure the cerebral metabolic rate for glucose.
Whereas glucose is well accepted as a primary
fuel for consumption by the brain, measurement
of 1CMRglc by itself provides only limited
information regarding the overall metabolic
demands and/or dysfunction in brain tissue.
Studies incorporating measures of CBF and
oxidative metabolism must also be conducted to
assure a more complete understanding of metabolic
changes that are produced by brain injury.
To our knowledge, studies specifically
addressing CBF following restricted ablation of
the cortex have not yet been conducted. CBF has
primarily been studied in models of cerebral
ischemia (Pulsinelli et al., 1982; Raichle, 1983;
Perani et al., 1987; LaManna et al., 1988;
Vannucci et al., 1988; Bolander et al., 1989;
Dimagl & Pulsinelli, 1990; Ginsberg, 1990) and
of experimental TBI (Lewelt et al., 1980; Dewitt et
al., 1986; McIntosh et al., 1987; Unterberg et al.,
1988; Yuan et al., 1988; Yamakami & Mclntosh,
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1989; 1991; Shima & Marmarou, 1991; Muir et al.,
1992). In cases where CBF was not directly
measured, the investigators measured ATP
(MacMillan, 1982; Pulsinelli & Duffy, 1983; Fass et
al., 1987; Komatsumoto et al., 1987), protein synthesis
(Lipton & Heimbaeh, 1977; Mies et al. 1991),
and extracellular lactate (Pulsinelli & Duffy, 1983;
Prasad et a1.,1994; Kawamata et al., 1995) to
determine whether flow is, in fact, adequate for
energy demands. Following brain injury, these
types of studies must be conducted using animals
at rest and under stimulated conditions to
incorporate and understand the metabolic
demands during different physiological conditions.
Clearly, such studies are currently impossible to
do in the same animal using autoradiographie or
tissue content analyses. In an effort to understand
the enduring metabolic demand of the brain
across both at-rest and activated conditions, many
studies have incorporated C.O. histochemistry for
measuring oxidative capacity (Hovda et al., 1987;
Shaw et al., 1988; Jen et al., 1989; Chiaia et al., 1991;
Hovda et al., 1991; Hovda& Villablanea, 1998).
As the most efficient method of generating
ATP, oxidative metabolism tends to run at a
relatively constant optimal level (Aekermann &
Lear, 1989; Barinaga, 1997). With its rate of use
dictated by the amount of cytoehrome e within
the mitochondria, oxidative metabolism can only
be upregulated above the maximal level via the
manufacture of additional protein. Given that the
production of protein can take anywhere from
hours to days, cells must rely on a more rapid
and dynamic process for satisfying the acute
increases in energy demands that are associated
with ionic pertubation and/or neuronal firing. It
would appear that this quickly responsive
process is glyeolysis, and this has been the basis
for the concept of energy compartmentalization
described in both cardiac and brain physiology.
This is one of many reasons why, when
measurements of glucose metabolism are
conducted using 2-DG autoradiography, a
physiological steady state must be maintained
throughout the uptake period (Sokoloffet al., 1977).
As has been described by many investigators
who are interested in the recovery of function
following brain injury, the very acute period after
injury is often quite dynamic in terms of the
energy demands being placed on cells, but the
most pronounced feature in the chronic state is a
widespread or generalized metabolic depression,
as studied using several different techniques. A
critical question is whether these longer, more
chronic measures of metabolism following injury
are simply an index for the current state of the
animal over a period of minutes (when 2-DG
techniques are used), or whether the overall set
point ofcerebral metabolism has been fundamentally
changed (Hovda et al., 1996; Hovda & Villablanca,
1998). In previous work on the pharmacology of
recovery from brain injury, we took the position,
along with others, that injury to the brain results
in a pronounced chronic depression of function,
reflected in measures of neurotransmitter levels
(Krobert et al., 1994), as well as in metabolism.
Evidence that drugs enhancing post-injury
behavioral recovery also alleviate injury-induced
hypometabolism provides support for such
concepts as remote functional depression or
diaschisis (Feeney et al., 1985; Feeney and Sutton,
1987; Feeney, 1991). In many cases, the metabolic
depression that is induced by brain injury may
diminish spontaneously, consistent with von
Monakow’s construct of diaschisis. Unfortunately,
von Monakow gave this concept a circular
definition, invoking the term diaschisis to explain
the spontaneous remission of symptoms after
injury. The measures of metabolic dysfunction
provide an independent measure of the concept,
eliminating his tautology. As demonstrated in the
current paper, as well as in prior studies (Feeney
et al., 1985; Hovda et al., 1987; Dietrich et al., 1990;
Hovda, 1996; Queen et al., 1997), the alleviation of
injury-induced metabolic depression can be markedly
enhanced with AMPH administration. If, as
hypothesized, metabolic depression contributes to
behavioral symptoms after brain injury, then
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pharmacological alleviation of the hypometabo-
lism would "enable" dysfunctional neurons so that
PT might activate the "performance" circuits that
are involved in functional deficits, whose activity
may also have been depressed by the injury.
That an indirect catecholaminergie agonist,
such as AMPH, would have the ability to
alleviate an injury-induced metabolic depression
provides some insight into the responsible
mechanisms. Over a number of years, we (Feeney
et al., 1985; Sutton & Feeney, 1992; Feeney, 1997;
1998a; 1998b) have advocated an NA hypothesis
incorporating the locus coeruleus, with others
(Pappius et al., 1988; Pappius, 1991) suggesting
that serotonin may be involved. Because AMPH
has nonspecific effects, it is important to determine
if other drugs releasing NA, such as yohimbine
and idazoxan, also improve functional outcome
and increase cerebral metabolism. Both
yohimbine and idazoxan have been shown to be
equivalent to AMPH in promoting functional
recovery in the rat hemiplegia model (Goldstein,
1988; Sutton & Feeney, 1992). Additionally,
these drugs increase cerebral metabolism, as
measured by PET-scan studies of rCBF (Schmidt
et al., 1995; Bremner et al., 1997). Significantly,
similar to the interaction between AMPH and PT
to promote recovery, no fixed action of AMPH
on cerebral glucose utilization occurs, but rather
the activated areas depend upon the task the
subject is doing during the period of drug action
(Mattay et al., 1996). Whatever the mechanism,
clearly an injury-induced metabolic depression is
related to the degree and to the extent of recovery
of function, given that recovery from deficits is
closely correlated with the recovery to normal
rates of cerebral metabolism (Hovda, 1996).
Cytochrome oxidase as a marker for oxidative
metabolic capacity
In a number of studies, the C.O. technique has
been used to characterize the cerebral oxidative
capacity in various brain regions. Some of these
studies include investigations addressing cerebral
maturation (Dehay & Kennedy, 1988; Hovda et al.,
1992), cerebral decortication (Hovda & Villablanca,
1998), and the effects of sensory deprivation or
stimulation (Kageyama & Wong-Riley, 1986; Wong-
Riley & Norton, 1988; Wong-Riley, 1989). As in the
current study, previous investigators have used
optical densitometry to assess C.O. activity in
regions of the cerebrum (Darriet et al., 1986; Hovda
et al., 1987, 1991, 1992; Kageyama & Meyer, 1988;
Hovda & Villablanca, 1990, 1998; Hyde & Dmimm,
1990). The intensity of C.O. staining, detected with
optical densitometry, correlates highly (r=.90)
with C.O. activity as measured using more traditional
spectrophotometric techniques (Dardet et al., 1986).
The analysis ofC.O. staining intensity in the current
study revealed several interesting alterations of
cerebral oxidative metabolism, induced by AMPH
administration and/or cortical ablation.
Effect of amphetamine in sham operates
Twenty-four hours after a single administration
of AMPH, C.O. histochemistry-assessed cerebral
oxidative metabolism was moderately decreased in
normal, sham-operated rats. AMPH administration
in rats has been reported to induce a widespread
activation of ICMRglc within 15 minutes (Porrino
et al., 1984). Such an acute increase in ICMRglc
after AMPH may be related to the rapid increase
in NA that has been reported after drug treatment
in rats (Krobert et al., 1994). In the current study,
the lack of C.O. increase in normal rats given
AMPH most likely reflects the fact that oxidative
metabolism in normal animals runs at peak
efficiency levels and, therefore, cannot be up-
regulated dynamically by a single injection of
AMPH. The depression of C.O. observed in our
study may be related to a "post-intoxication"
effect of AMPH, reflecting the after effects of an
initial global neural activation by this drug. In
normal human subjects, AMPH was reported to
slightly decrease 1CMRglc in cortical regions by
3 hours post-drug (Wolkin et al., 1987).
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Cerebral metabolic depression after
injury and the effect of amphetamine
brain
The current results indicate that 48 hours
following unilateral sensorimotor cortex ablation,
oxidative capacity, assessed by C.O. histo-
chemistry, is decreased in several remote,
ipsilateral motor structures, including the nucleus
accumbens, caudate-putamen, globus pallidus,
red nucleus, and superior colliculus. Prior studies
using cortical freezing lesion, ablation, concussion,
contusion, or stroke-injury models have also
reported a depression of both cerebral oxidative
(Dail et al., 1981; Feeney et al., 1985; Hovda et al.,
1991; Hovda, 1996;) and glycolytic (Pappius, 1981;
Feeney et al., 1985; Colleet al., 1986; Pappius et al.,
1988; Sutton et al., 1989a; Dielrich et al., 1990;
Yoshino et al., 1991; Queen et al., 1997) metabolism.
As with the current findings, such injury-induced
metabolic depressions are most evident within
the ipsilateral cortical and/or subcortical regions
during the first few days post injury. The
physiological consequences of these injury-
induced metabolic depressions may be functionally
related to the neurobehavioral deficits in the
contralateral limbs that are exhibited during this
same time period post injury (Feeney et al., 1982;
Feeney & Sutton, 1987, 1988; Gilman et al., 1987;
Sutton et al., 1987; Sutton & Feeney, 1992).
AMPH-induced alleviation of metabolic
depression may contribute to the ability of the
drug to alleviate symptoms (Feeney, 1998b),
which has been extended to stroke patients
(reviewed in Goldstein, 1993; Feeney, 1997).
This effect has also been demonstrated by Hovda
and his colleagues (1996), who showed that the
AMPH-induced alleviation of metabolic depression
following fluid percussion injury was directly
related to an increased rate of behavioral
recovery.
Prior research on cortical concussion injury
(Hovda et al., 1991) revealed that a decrease in
C.O. stain intensity appears to be restricted to
regions ipsilateral to the injury, and a significant
depression is not attained until 5 days post
injury. Similarly, the decreased staining of the
oxidative enzyme alpha glycerophosphate
dehydrogenase that occurs following laceration,
ablation, or contusion injury of the sensorimotor
cortex, is restricted to regions of the cortex
ispilateral to injury and is detectable at 36 hours
post injury, and persisting for 9 days (Dail et al.,
1981). This enzyme depletion is not lessened by
AMPH, but can be prevented by giving the drug
during the first 24 hours post injury (Feeney et at,
1985). In the current study, a significant decrease
in C.O. activity in the contralateral cerebral cortex,
superior colliculus, and red nucleus was evident 2
days following ablation of the right sensorimotor
cortex. This finding may indicate that for the
detection of depressed oxidative metabolism, the
C.O. histochemistry method is more sensitive
than staining for alpha glycerophosphate
dehydrogenase activity (Feeney et al., 1985). The
relatively early, bilateral depression of C.O.
activity after suction ablation but not after
concussion, produced by fluid percussion (Hovda
et al., 1991), suggests that either the severity of
injury or the trauma model used influences both
the extent and the onset of significant metabolic
depression. Unlike ablation, after contusion of the
sensorimotor cortex, an increase in C.O. in the
ipsilateral auditory and entorhinal cortex has
been observed (Weisend et al., 1990). This
increase in C.O. after contusion injury may be
related to the recurring seizures that have been
reported after this type of injury (Krobert et al.,
1992; Nilsson et al., 1994).
The current results indicate that acute
administration of AMPH (24 hours after injury)
is capable of attenuating the bilateral remote
functional depression of oxidative metabolism
that is produced by unilateral cortical ablation.
That AMPH treatment alleviated the depressed
oxidative metabolism in all structures examined
suggests that the drug exhibits a global effect on
neural metabolism. This result is consistent with
the hypothesis that AMPH may exert its effects
on cerebral metabolism via actions either on the
noradrenergic (Feeney et al., 1985; Feeney &
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Sutton, 1987; 1988; Feeney 1998b) or on the
serotonergie (Pappius, 1991) neurotransmitter
systems, which provide diffuse cerebral innervation.
That bilateral reductions in C.O. were found
in some structures (for example, cerebral cortex,
red nucleus, and superior eollieuli) after unilateral
sensorimotor cortex ablation, and that AMPH
treatment alleviated both ipsilateral and eontra-
lateral depression of oxidative capacity in injured
rats may not, at first glance, appear to be
compatible with the hypothesis that the drug-
induced alleviation of hypometabolism is related
to functional recovery. Nevertheless, some evidence
exists for a role of the eontralateral hemisphere
in recovery (Dietrich et al., 1990). Most studies
on the effect ofAMPH on functional recovery after
unilateral cortex ablation have employed the
beam-walking scale developed by Feeney and
colleagues (Feeney et al., 1982; Sutton & Feeney,
1992) for assessing ontralateral hindlimb
dysfunction. Albeit this rating scale for assessing
the recovery from hemiplegia focuses on the
ability of the injured animal to use the
eontralateral hindlimb, in some animals mild and
transient deficits in the use of the ipsilateral
hindlimb have been observed during beam-walk
tests. When using the scale to rate both ipsilateral
and eontralateral limbs during beam-walk testing,
a very mild and transient deficit can be seen in
the ipsilateral hindlimb (Feeney, personal obser-
vation), which may contribute to the inability of
some rats to traverse the beam during the first
few days after injury. Mild and transient deficits
in the hindlimb ipsilateral to cortical contusion
injury (specifically, delayed response times to
retract the limb after lateral and posterior
displacement (Sutton et al., 1990), has also been
observed. At present, we can only speculate that
a bilateral decrease in oxidative capacity may
contribute to these bilateral deficits, and that an
AMPH-induced alleviation of this decreased
oxidative metabolism may facilitate recovery in
both the ipsilateral and the contralateral limbs.
Firm conclusions will depend upon further
studies employing both behavioral tasks that are
sensitive to potential bilateral deficits and
analyses of potential bilateral metabolic responses
to injury and/or drug treatment.
In conclusion, this study has demonstrated
that a single AMPH treatment attenuates the
depression of the cerebral oxidative metabolism
that occurs after unilateral sensorimotor cortex
ablation. We previously reported that AMPH
treatment attenuates the decrease in ICMRglc
and the paling of alpha glycerophosphate
dehydrogenase staining that occurs after
sensorimotor cortex injury (Feeney et al., 1985;
Queen et al., 1997). Likewise, Dietrich et al. (1990)
reported that AMPH treatment increases
ICMRglc in cortical regions following photo-
chemically induced cortical infarcts. These
effects of AMPH on cerebral metabolism after
cortical injury support a general hypothesis
(Feeney et al., 1985; Hovda et al., 1987; Feeney
& Sutton, 1987, 1988; Feeney, 1991; Feeney, 1998a,
1998b) that AMPH may exert its beneficial
effects on behavioral recovery by alleviating a
metabolic dysfunction (namely, a remote functional
depression) that is induced by cortical injury.
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